Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 9/20 | 0.39 |
| ▸ | FEN1 | P39748 | 9/20 | 0.39 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.34 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.34 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.34 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14844537 | 0.80 | ALOX5AP (0.44) | ALOX5APFEN1DDR1HIF1ASCN9A | |
| SCHEMBL29464818 | 0.80 | ALOX5AP (0.44) | ALOX5APFEN1DDR1HIF1ASCN9A | |
| SCHEMBL16007810 | 0.80 | ALOX5AP (0.38) | ALOX5APFEN1ITGB1ITGA4ITGB7 | |
| SCHEMBL16008283 | 0.78 | ALOX5AP (0.40) | ALOX5APFEN1DDR1SCN9AADRA1A | |
| SCHEMBL16007991 | 0.77 | ALOX5AP (0.42) | ALOX5APFEN1ITGB1ITGA4ITGB7 | |
| SCHEMBL14844339 | 0.76 | ALOX5AP (0.43) | ALOX5APFEN1DDR1SCN9A | |
| SCHEMBL14844503 | 0.76 | ALOX5AP (0.41) | ALOX5APFEN1ITGB1ITGA4ITGB7 | |
| SCHEMBL27962367 | 0.75 | ALOX5AP (0.39) | ALOX5APFEN1ITGB1ITGA4ITGB7 | |
| SCHEMBL16007811 | 0.75 | ALOX5AP (0.41) | ALOX5APFEN1ITGB1ITGA4ITGB7 | |
| SCHEMBL14844504 | 0.75 | ALOX5AP (0.40) | ALOX5APFEN1ITGB1ITGA4ITGB7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9693556-B2 | Herbicidal pyridazinone derivatives | SYNGENTA LIMITED (GB) | 2017-07-04 | — | — | US | disclosed |
| US-20140256546-A1 | HERBICIDAL PYRIDAZINONE DERIVATIVES | SYNGENTA LIMITED (GB) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256546-A1 | HERBICIDAL PYRIDAZINONE DERIVATIVES | PRDX6, PRDX1, CBR3 | ALOX5AP 2897/4885FEN1 3660/4885ITGB1 3671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.